Acquisition by Deborah Yount of tradable shares of AtriCure subject to Rule 16b-3
| ATRC Stock | USD 40.96 0.37 0.90% |
About 62% of AtriCure's investor base is looking to short. The analysis of overall sentiment of trading AtriCure stock suggests that many investors are alarmed at this time. The current market sentiment, together with AtriCure's historical and current headlines, can help investors time the market. In addition, many technical investors use AtriCure stock news signals to limit their universe of possible portfolio assets.
AtriCure |
Filed transaction by Atricure Inc officer. Grant, award or other acquisition pursuant to Rule 16b-3(d)
Read at macroaxis.com
AtriCure Fundamental Analysis
We analyze AtriCure's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of AtriCure using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of AtriCure based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Beta
Beta Comparative Analysis
AtriCure is currently under evaluation in beta category among its peers. Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
AtriCure Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with AtriCure stock to make a market-neutral strategy. Peer analysis of AtriCure could also be used in its relative valuation, which is a method of valuing AtriCure by comparing valuation metrics with similar companies.
Peers
AtriCure Related Equities
| ANGO | AngioDynamics | 1.93 | ||||
| LMAT | LeMaitre Vascular | 1.32 | ||||
| AXGN | Axogen | 2.91 | ||||
| CNMD | CONMED | 8.97 |
Complementary Tools for AtriCure Stock analysis
When running AtriCure's price analysis, check to measure AtriCure's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AtriCure is operating at the current time. Most of AtriCure's value examination focuses on studying past and present price action to predict the probability of AtriCure's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AtriCure's price. Additionally, you may evaluate how the addition of AtriCure to your portfolios can decrease your overall portfolio volatility.
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |